Skip to content

Persistence rate of out-patients visit in glaucoma patients (Collect additional data)

Persistence rate of out-patients visit in glaucoma patients (Collect additional data) - Persistence rate of out-patients visit in glaucoma patients (Collect additional data)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037770
Enrollment
28
Registered
2019-08-22
Start date
2019-08-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Sponsors

Santen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Twenty eight patients who persisted over 180-days continuous visit in the phase 2 of preceding glaucoma persistence rate study conducted by Santen

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Intraocular pressure change between pre and post persisting visit

Countries

Japan

Contacts

Public ContactNaomi Otsuka

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs Group, Development Management Department, Japan Business

clinical@santen.co.jp06-4802-9337

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026